Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …

Abstract Purpose of Review The diagnosis of gastric neuroendocrine tumors (NETs) is being
made with increased frequency likely as a result of more upper endoscopies being done for …

Gastric neuroendocrine tumors (GNETs) are rare lesions characterized by hypergastrinemia
that arise from enterochromaffin-like cells of the stomach. GNETs consist of a heterogeneous …

Background Long‐term observational studies assessing the incidence of type I gastric
carcinoid (typeIGC) in patients with chronic atrophic gastritis are few. Aim To evaluate the …

Gastric neuroendocrine neoplasms (g-NENs) or neuroendocrine tumors are generally slow-
growing tumors with increasing incidence. They arise from enterochromaffin like cells and …

Background and Aim Type I gastric carcinoids (TIGC) are associated with chronic atrophic
gastritis (CAG) with hypergastrinemia and hyperplasia of enterochromaffin‐like cells …

Background Type I gastric neuroendocrine tumors (GNETs) are typically managed either
expectantly or endoscopically. In contrast, locoregional surgery has been recommended for …

Summary Background Neuroendocrine tumours (NETs) of the stomach and duodenum are
rare, but are increasing in incidence. Optimal management of localised, low‐grade gastric …

Background A number of different therapies, including endoscopic resection, have been
suggested for the treatment of Type 1 gastric neuroendocrine tumors (NETs). The current …

Purpose Type I gastric neuroendocrine neoplasms (g-NENs) have a low risk of metastasis
and a generally favourable prognosis. Patients with small type I g-NENs (≤ 10 mm) …